Takeda locks up global rights to Intra-Cellular's PDE1 inhibitors
04 March 2011
Ian Haydock
Please Login to read the full article.
04 March 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- AstraZeneca dumps Targacept's antidepressant TC-5214 after two more Ph III failures
- Bionomics set to enter Alzheimer's fray with new candidates
- Merck hands back preclinical Parkinson's disease assets to Addex
- Boehringer Ingelheim provides new home for biocrea's BBB-crossing PDE2 inhibitors
ANALYSIS
Other Informa Analysis
FEATURES
- DKSH highlights one-stop benefits as it builds Asia market expansion services
- Interview: Adimab's Gerngross seeks two sweethearts
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
